Every Cadence Company is Engineered for Acquisition
BUILT FOR STRATEGIC OUTCOMES
From seed to scale, we invest with the exit in mind—de-risking, creating value, and building what acquirers want to buy. We spot high-value opportunities before they hit the market, leveraging board seats, deep relationships, and a reputation that opens doors.
Our high-trust ecosystem fuels deal flow, diligence, and strategic engagement. We don’t wait for exits—we build toward them through early alignment with acquirers and a proven record of landmark outcomes.
New York, NY
Conceivable Life Sciences is reimagining the IVF lab with fully automated, AI-powered systems that enhance precision and outcomes in reproductive medicine.
Oakland, CA
Koya Medical is developing an innovative, active compression system for treating lymphedema and venous insufficiency through smart, wearable therapy.
Oakland, CA
Lhotse Medical is a stealth-mode MedTech company, advancing novel ophthalmic solutions to transform eye care and vision outcomes.
Tempe, AZ
Nectero Medical is a clinical-stage biotech company, pioneering novel endovascular therapies to stabilize and treat aneurysmal disease.
Milwaukee, WI
Rivermark Medical is developing the preferred first-line, office-based device therapy for benign prostatic hyperplasia (BPH).
Santa Cruz, CA
Versa Vascular is building a catheter-based implant to restore function and treat tricuspid valve regurgitation through a minimally invasive approach.
Los Gatos, CA
Venova Medical is advancing novel vascular technologies designed to improve blood flow and patient outcomes in complex peripheral interventions.
Cardiff, CA
Field Medical is developing a next-generation cardiac ablation platform to precisely and efficiently treat atrial fibrillation and other arrhythmias.
Milford, MA
Reprieve Cardiovascular is developing an automated fluid-management platform to improve outcomes for patients with acute decompensated heart failure.
San Francisco, CA
Spirair is creating breakthrough ENT and respiratory solutions to address chronic sinus and airway conditions with less invasive, more effective therapies.
Irvine, CA
Beta Bionics is pioneering the iLet® Bionic Pancreas — an automated, integrated insulin-delivery system designed to simplify life for people with diabetes.